INS and type 2 diabetes mellitus: The BARI‐2D trial is a prospective RCT that included 2368 patients with type II diabetes and stable coronary artery disease to receive either prompt revascularization (percutaneous coronary intervention or coronary‐artery bypass grafting) with intensive medical therapy or intensive medical therapy alone followed by insulin‐sensitization or insulin‐provision therapy alone (Frye et al., 2009).